| |
|
Press Contact:
Jessica Switzer
Switzer Communications, Inc.
415-945-7070
Jessica@switz.com
Biotech Automation Company, Korvis Automation Inc. Introduces
Korvis Platform™
___
Company Makes it Easier for Biotech Research,
Development, and
Manufacturing Teams to Accelerate the Development of Process and
Product
SEATTLE, April 15, 2002 – Korvis Automation,
Inc., a new biotech automation company, announced today the launch
of its Korvis Platform. Korvis Automation’s new technology
is designed for use by biotech researchers, scientists, and manufacturing
teams to address the ever-increasing demands in the burgeoning
area of life sciences. The company also announced the opening
of its Seattle offices.
“This is an exciting time for biotech automation and Korvis
Automation’s approach, which allows custom-designed automation
and instrumentation to be delivered in a fraction of the previously
allotted time, has the potential to change the way process development
is done,” said Ben Wahlstrom, CEO of Korvis.
As researchers delve further into the genome and enter the era
of proteomics, they generate unprecedented amounts of biological
sample media. Aggressive product development cycles across the
life science industry are pushing current techniques beyond their
capabilities. Standard practices are proving inadequate and facilities
are overwhelmed by inefficient methods. Integration and design
of complex automation systems only further overwhelm the resources
of many labs and biotech manufacturing facilities. To overcome
this challenge, several labs and biotech companies have already
recognized a model that mature industries have used for years
– to outsource the design and integration of automation to
companies specializing in machine design, control and process
development.
Korvis’ newest technology, the Korvis Platform, is a revolutionary
instrument platform that is customized based on customer specifications.
The Korvis Platform incorporates the necessary mechanical structure,
pneumatic and electrical support systems, controller and software
to bear the most demanding applications. The platform is uniquely
tailored for biotech automation. It offers clean-room level environmental
filtration, ergonomic comfort, biotech compatible materials, standard
fluidic control, humidity control modules, and advanced software
control schemes.
The company is privately funded. Customers already include Boston-based
Gene XP, a biotech startup with unique IP in the biochip array
sector and others
We chose Korvis Automation for several reasons,”
said Paul Davis, Director, of Gene XP, “First off, the seasoned
leadership and engineering prowess of the Korvis group, led by
Ben Wahlstrom, was a real plus for us. We know first hand that
Ben and his team deliver first-rate results, and we view this
relationship as a long-term partnership. Second, due to the highly
complex engineering required, it is imperative that our chosen
vendor be well versed in the delivery of a complete turnkey system.
The Korvis group offers the integration necessary to bring our
products to market. ”
About Korvis Automation, Inc.
Korvis Automation, Inc., based in Seattle
Washington, is a biotech automation company. The company’s
new technology, the Korvis Platform, is an innovative system for
improving the efficiencies of development cycles. The Korvis Platform
allows companies and research institutions to accelerate the development
of process and product. The Korvis team is comprised of the industry’s
leading engineers with extensive experience in complex control
schemes, process development, life science product design, optics,
machine vision, and precision motion platforms. The company is
privately funded and has already established itself by servicing
several strategic customer wins.
### |
